BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 32162734)

  • 1. Copper-Enriched Prussian Blue Nanomedicine for In Situ Disulfiram Toxification and Photothermal Antitumor Amplification.
    Wu W; Yu L; Pu Y; Yao H; Chen Y; Shi J
    Adv Mater; 2020 Apr; 32(17):e2000542. PubMed ID: 32162734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-delivery of nanoparticle and molecular drug by hollow mesoporous organosilica for tumor-activated and photothermal-augmented chemotherapy of breast cancer.
    Zhang H; Song F; Dong C; Yu L; Chang C; Chen Y
    J Nanobiotechnology; 2021 Sep; 19(1):290. PubMed ID: 34579711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanomedicine Enables Drug-Potency Activation with Tumor Sensitivity and Hyperthermia Synergy in the Second Near-Infrared Biowindow.
    Liu W; Xiang H; Tan M; Chen Q; Jiang Q; Yang L; Cao Y; Wang Z; Ran H; Chen Y
    ACS Nano; 2021 Apr; 15(4):6457-6470. PubMed ID: 33750100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced Tumor-Specific Disulfiram Chemotherapy by
    Wu W; Yu L; Jiang Q; Huo M; Lin H; Wang L; Chen Y; Shi J
    J Am Chem Soc; 2019 Jul; 141(29):11531-11539. PubMed ID: 31251050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diethyldithiocarbamate-copper nanocomplex reinforces disulfiram chemotherapeutic efficacy through light-triggered nuclear targeting.
    Ren L; Feng W; Shao J; Ma J; Xu M; Zhu BZ; Zheng N; Liu S
    Theranostics; 2020; 10(14):6384-6398. PubMed ID: 32483459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disulfiram-loaded hollow copper sulfide nanoparticles show anti-tumor effects in preclinical models of colorectal cancer.
    Jiapaer Z; Zhang L; Ma W; Liu H; Li C; Huang W; Shao S
    Biochem Biophys Res Commun; 2022 Dec; 635():291-298. PubMed ID: 36327916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppressing autophagy enhances disulfiram/copper-induced apoptosis in non-small cell lung cancer.
    Wu X; Xue X; Wang L; Wang W; Han J; Sun X; Zhang H; Liu Y; Che X; Yang J; Wu C
    Eur J Pharmacol; 2018 May; 827():1-12. PubMed ID: 29547841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disulfiram-loaded metal organic framework for precision cancer treatment via ultrasensitive tumor microenvironment-responsive copper chelation and radical generation.
    Zhang H; Zhang Q; Guo Z; Liang K; Boyer C; Liu J; Zheng Z; Amal R; Yun SLJ; Gu Z
    J Colloid Interface Sci; 2022 Jun; 615():517-526. PubMed ID: 35152072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glutathione-responsive copper-disulfiram nanoparticles for enhanced tumor chemotherapy.
    Chen M; Huang Z; Xia M; Ding Y; Shan T; Guan Z; Dai X; Xu X; Huang Y; Huang M; Zhao C
    J Control Release; 2022 Jan; 341():351-363. PubMed ID: 34856225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zn
    Shou P; Yu Z; Wu Y; Feng Q; Zhou B; Xing J; Liu C; Tu J; Akakuru OU; Ye Z; Zhang X; Lu Z; Zhang L; Wu A
    Adv Healthc Mater; 2020 Jan; 9(1):e1900948. PubMed ID: 31746549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zwitterion-functionalized hollow mesoporous Prussian blue nanoparticles for targeted and synergetic chemo-photothermal treatment of acute myeloid leukemia.
    Bai H; Sun Q; Kong F; Dong H; Ma M; Liu F; Wang C; Xu H; Gu N; Zhang Y
    J Mater Chem B; 2021 Jul; 9(26):5245-5254. PubMed ID: 34095945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-Microenvironment-Responsive Cerium-Enriched Copper Nanozyme with O
    Lin J; Huang C; Wang P; He Y; Luo Q; Liu X; Li Y
    Adv Healthc Mater; 2024 Apr; 13(11):e2303955. PubMed ID: 38271271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biodegradable Nanocatalyst with Self-Supplying Fenton-like Ions and H
    Li W; Zhou X; Liu S; Zhou J; Ding H; Gai S; Li R; Zhong L; Jiang H; Yang P
    ACS Appl Mater Interfaces; 2021 Nov; 13(43):50760-50773. PubMed ID: 34672620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disulfiram/copper shows potent cytotoxic effects on myelodysplastic syndromes via inducing Bip-mediated apoptosis and suppressing autophagy.
    Zha J; Bi S; Deng M; Chen K; Shi P; Feng L; He J; Pu X; Guo C; Zhao H; Li Z; Jiang Y; Song H; Xu B
    Eur J Pharmacol; 2021 Jul; 902():174107. PubMed ID: 33865831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A tumor microenvironment-responsive core-shell tecto dendrimer nanoplatform for magnetic resonance imaging-guided and cuproptosis-promoted chemo-chemodynamic therapy.
    Ni C; Ouyang Z; Li G; Liu J; Cao X; Zheng L; Shi X; Guo R
    Acta Biomater; 2023 Jul; 164():474-486. PubMed ID: 37040813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disulfiram-gold-nanorod integrate for effective tumor targeting and photothermal-chemical synergistic therapy.
    Xu C; Zhang T; Lu G; Chen K; Tao J; Zhang Y; Teng Z; Yang B
    Biomater Sci; 2020 Jun; 8(12):3310-3319. PubMed ID: 32400782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A dual gate-controlled intelligent nanoreactor enables collaborative precise treatment for cancer nanotherapy.
    Zhang H; Tang W; Gong Q; Yang X; Sun Y; Dai Z; Hu Z; Zheng X
    Nanoscale; 2022 Sep; 14(36):13113-13122. PubMed ID: 36052962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disulfiram-loaded copper sulfide nanoparticles for potential anti-glioma therapy.
    Lan QH; Du CC; Yu RJ; Zhai J; Shi Y; Kou L; Xiao J; Lu CT; Zhao YZ; Yao Q
    Int J Pharm; 2021 Sep; 607():120978. PubMed ID: 34371152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disulfiram/copper markedly induced myeloma cell apoptosis through activation of JNK and intrinsic and extrinsic apoptosis pathways.
    Xu Y; Zhou Q; Feng X; Dai Y; Jiang Y; Jiang W; Liu X; Xing X; Wang Y; Ni Y; Zheng C
    Biomed Pharmacother; 2020 Jun; 126():110048. PubMed ID: 32145587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disulfiram Copper Nanoparticles Prepared with a Stabilized Metal Ion Ligand Complex Method for Treating Drug-Resistant Prostate Cancers.
    Chen W; Yang W; Chen P; Huang Y; Li F
    ACS Appl Mater Interfaces; 2018 Dec; 10(48):41118-41128. PubMed ID: 30444340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.